182 related articles for article (PubMed ID: 34860284)
1. Anxiety and cognitive-related effects of Δ
Hudson R; Norris C; Szkudlarek HJ; Khan D; Schmid S; Rushlow WJ; Laviolette SR
Psychopharmacology (Berl); 2022 Feb; 239(2):509-524. PubMed ID: 34860284
[TBL] [Abstract][Full Text] [Related]
2. Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states.
Fitoussi A; Zunder J; Tan H; Laviolette SR
Eur J Neurosci; 2018 Jun; 47(11):1385-1400. PubMed ID: 29776015
[TBL] [Abstract][Full Text] [Related]
3. l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.
De Felice M; Renard J; Hudson R; Szkudlarek HJ; Pereira BJ; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2021 Jan; 41(4):739-750. PubMed ID: 33268546
[TBL] [Abstract][Full Text] [Related]
4. The Bivalent Rewarding and Aversive properties of Δ
Norris C; Szkudlarek HJ; Pereira B; Rushlow W; Laviolette SR
Sci Rep; 2019 Jul; 9(1):9760. PubMed ID: 31278333
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
6. Adolescent nicotine induces depressive and anxiogenic effects through ERK 1-2 and Akt-GSK-3 pathways and neuronal dysregulation in the nucleus accumbens.
Hudson R; Green M; Wright DJ; Renard J; Jobson CEL; Jung T; Rushlow W; Laviolette SR
Addict Biol; 2021 Mar; 26(2):e12891. PubMed ID: 32135573
[TBL] [Abstract][Full Text] [Related]
7. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
8. THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways.
Szkudlarek HJ; Rodríguez-Ruiz M; Hudson R; De Felice M; Jung T; Rushlow WJ; Laviolette SR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110029. PubMed ID: 32623021
[TBL] [Abstract][Full Text] [Related]
9. Sex-Dependent Synergism of an Edible THC: CBD Formulation in Reducing Anxiety and Depressive-like Symptoms Following Chronic Stress.
Pérez-Valenzuela E; Hudson R; Uzuneser T; De Felice M; Szkudlarek H; Rushlow W; Laviolette SR
Curr Neuropharmacol; 2023 Sep; ():. PubMed ID: 37702237
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic nicotine exposure on Δ
Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
[TBL] [Abstract][Full Text] [Related]
11. Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.
Szkudlarek HJ; Desai SJ; Renard J; Pereira B; Norris C; Jobson CEL; Rajakumar N; Allman BL; Laviolette SR
Neuropsychopharmacology; 2019 Mar; 44(4):817-825. PubMed ID: 30538288
[TBL] [Abstract][Full Text] [Related]
12. Female but not male rats show biphasic effects of low doses of Δ
Salviato BZ; Raymundi AM; Rodrigues da Silva T; Salemme BW; Batista Sohn JM; Araújo FS; Guimarães FS; Bertoglio LJ; Stern CA
Neuropharmacology; 2021 Sep; 196():108684. PubMed ID: 34181978
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
Loureiro M; Kramar C; Renard J; Rosen LG; Laviolette SR
Biol Psychiatry; 2016 Aug; 80(3):216-25. PubMed ID: 26681496
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
16. Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ
Hwang EK; Lupica CR
Biol Psychiatry; 2020 Apr; 87(7):619-631. PubMed ID: 31543247
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine exposure attenuates the effects of Δ
Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
[TBL] [Abstract][Full Text] [Related]
18. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
20. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
